Research on Stock Adjustment Model of Chinese Pharmaceutical Industry in the Reforming Process of Mixed Ownership

Shengyi Shi, Guangping Wang, Yanfei Huo, Baxian Yi, Xiaoming Wu

Abstract


The aim of Chinese pharmaceutical industry restructuring and upgrading is to achieve the transformation from incremental expansion to the stock adjustment road. As the mail strength of industrial restructuring, pharmaceutical companies of state-owned and state-holding are the main object of pharmaceuticals industry mixed ownership reforms. Basing on the analyzing of mixed ownership reforming process and industry restructuring, the paper discussed the impacting factors of Chinese pharmaceutical restructuring with the empirical analysis of Panel Data model. Result display that the state-owned companies perform the more quantity, extensive mode of production, which need the stock adjustment model. Restructuring road include the incremental and stock adjusting, micro-stock adjusting, social capital participating and state-owned capital exchange building.

Full Text:

PDF


DOI: https://doi.org/10.5539/par.v5n2p104

Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 Shengyi Shi, Guangping Wang, Yanfei Huo, Baxian Yi, Xiaoming Wu

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Public Administration Research  ISSN 1927-517X  (Print)  ISSN 1927-5188  (Online)  Email: par@ccsenet.org

Copyright © Canadian Center of Science and Education

To make sure that you can receive messages from us, please add the 'ccsenet.org' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.